nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biomarker-based dissection of neurodegenerative diseases
|
Olsson, Bob |
|
2011 |
95 |
4 |
p. 520-534 15 p. |
artikel |
2 |
Biomarkers and evolution in Alzheimer disease
|
Rapoport, Stanley I. |
|
2011 |
95 |
4 |
p. 510-513 4 p. |
artikel |
3 |
Biomarkers for Alzheimer's disease therapeutic trials
|
Hampel, Harald |
|
2011 |
95 |
4 |
p. 579-593 15 p. |
artikel |
4 |
Biomarkers for major depression and its delineation from neurodegenerative disorders
|
Schneider, Barbara |
|
2011 |
95 |
4 |
p. 703-717 15 p. |
artikel |
5 |
Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements
|
Broich, Karl |
|
2011 |
95 |
4 |
p. 498-500 3 p. |
artikel |
6 |
Biomarkers in frontotemporal lobar degenerations—Progress and challenges
|
Hu, William T. |
|
2011 |
95 |
4 |
p. 636-648 13 p. |
artikel |
7 |
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
|
Henchcliffe, Claire |
|
2011 |
95 |
4 |
p. 601-613 13 p. |
artikel |
8 |
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression
|
Teipel, Stefan J. |
|
2011 |
95 |
4 |
p. 547-556 10 p. |
artikel |
9 |
Development of biomarkers for multiple sclerosis as a neurodegenerative disorder
|
Ziemann, Ulf |
|
2011 |
95 |
4 |
p. 670-685 16 p. |
artikel |
10 |
Discovery and development of integrative biological markers for schizophrenia
|
Oertel-Knöchel, Viola |
|
2011 |
95 |
4 |
p. 686-702 17 p. |
artikel |
11 |
Editorial Board
|
|
|
2011 |
95 |
4 |
p. CO2- 1 p. |
artikel |
12 |
Ethical considerations of biomarker use in neurodegenerative diseases—A case study of Alzheimer's disease
|
Prvulovic, David |
|
2011 |
95 |
4 |
p. 517-519 3 p. |
artikel |
13 |
Functional biomarkers for neurodegenerative disorders based on the network paradigm
|
Horwitz, Barry |
|
2011 |
95 |
4 |
p. 505-509 5 p. |
artikel |
14 |
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
|
Prvulovic, David |
|
2011 |
95 |
4 |
p. 557-569 13 p. |
artikel |
15 |
Imaging biomarkers in Parkinson's disease
|
Brooks, David J. |
|
2011 |
95 |
4 |
p. 614-628 15 p. |
artikel |
16 |
Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention
|
Trojanowski, John Q. |
|
2011 |
95 |
4 |
p. 491-495 5 p. |
artikel |
17 |
Neuroimaging and the question of neurodegeneration in schizophrenia
|
Meyer-Lindenberg, Andreas |
|
2011 |
95 |
4 |
p. 514-516 3 p. |
artikel |
18 |
On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia
|
Geser, F. |
|
2011 |
95 |
4 |
p. 649-662 14 p. |
artikel |
19 |
Perspectives of worldwide translational biomarker research in neurodegenerative diseases
|
Nicotera, Pierluigi |
|
2011 |
95 |
4 |
p. 496-497 2 p. |
artikel |
20 |
Prevention trials in Alzheimer's disease: An EU-US task force report
|
Vellas, Bruno |
|
2011 |
95 |
4 |
p. 594-600 7 p. |
artikel |
21 |
Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's disease
|
Hampel, Harald |
|
2011 |
95 |
4 |
p. 570-578 9 p. |
artikel |
22 |
Staging Alzheimer's disease progression with multimodality neuroimaging
|
Ewers, Michael |
|
2011 |
95 |
4 |
p. 535-546 12 p. |
artikel |
23 |
The ALS/PDC syndrome of Guam: Potential biomarkers for an enigmatic disorder
|
McGeer, Patrick L. |
|
2011 |
95 |
4 |
p. 663-669 7 p. |
artikel |
24 |
The future of Alzheimer's disease: The next 10 years
|
Hampel, Harald |
|
2011 |
95 |
4 |
p. 718-728 11 p. |
artikel |
25 |
The Parkinson Progression Marker Initiative (PPMI)
|
Marek, Kenneth |
|
2011 |
95 |
4 |
p. 629-635 7 p. |
artikel |
26 |
The role of genetics for biomarker development in neurodegeneration
|
Bertram, Lars |
|
2011 |
95 |
4 |
p. 501-504 4 p. |
artikel |